Company Name: Oxford Immunotec Global PLC
Oxford Immunotec Global PLC is an immunology diagnostic company. The company develops diagnostics for immune related conditions using its proprietary T-SPOT platform. The company’s first product, the T-SPOT.TB test, is used to test for latent Tuberculosis infection (LTBI).
Ticker Symbol: OXFD (NASDAQ)
Company Website: www.oxfordimmunotec.com
Headquarters: Oxfordshire, UK